For at least 20 years, Republicans have been pushing for giving tax credits to help individuals buy health insurance. The Supreme Court’s latest Obamacare ruling does Republicans the favor of preserving them.
Kelly Huntington, president and CEO of Indianapolis Power & Light Co., has stepped down to become senior vice president of enterprise strategy at OneAmerica Financial Partners Inc., the companies announced Thursday.
London Mayor Boris Johnson is proposing a $16 billion fund to encourage growth of emerging health-care companies in the United Kingdom in an effort to catch up to biotechnology clusters in the United States.
Eli Lilly and Co. received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Eli Lilly and Co. has been ordered to face claims it misled consumers about “brain zaps” and other withdrawal side effects tied to its antidepressant Cymbalta in the first cases slated to be heard by juries.
CFO Fred J. Crawford joined CNO Financial Group in 2012 and is credited with helping turn around the insurance holding company.
The Indiana-based company has taken the name Zimmer Biomet Holdings Inc. and will trade under the ticker symbol to "ZBH" on Monday. Zimmer Holdings Inc. agreed to buy privately-held Biomet in April 2014.
A victory by Anthem Inc. in its bid to buy Cigna Corp. could create regulatory hurdles for other insurers exploring deals as antitrust officials seek to hold the line on rising health care costs.
About 160,000 low- and moderate-income Indiana residents could lose health insurance premium subsidies provided under the Affordable Care Act if the U.S. Supreme Court rules them illegal, two groups estimated Tuesday.
Cigna Corp. and Anthem Inc. are poised to do the biggest deal that the health insurance industry has ever seen—if their CEOs can get along.
In a new scoring system for oncology drugs, a leading group of U.S. cancer doctors awarded a zero for overall benefit to a regimen featuring Alimta, Eli Lilly and Co.’s top-selling product.
Cigna said Anthem’s a risky bet due to fallout from its massive data breach, lawsuits that accuse it of conspiring to inflate prices, and lack of a growth strategy. But Wall Street thinks this deal is going to happen, unless Cigna can find another buyer.
Indianapolis-based Anthem Inc. said Monday that the merged companies would cover more than 53 million people combined, a total that easily surpasses that of current market leader, UnitedHealth Group Inc.
Driving the consolidation is the 2010 health law that put tougher rules on the industry, demanding more covered services, better care and a ceiling on profits.
Anthem on Saturday offered to buy the smaller health insurer, which responded Sunday with a litany of concerns and criticisms.
One of the stumbling blocks to a deal has been Cigna’s insistence that its CEO, David Cordani, serve as CEO of the merged company.
But hospitals’ list prices in Indiana are more than three times what the federal Medicare program pays.
After years of pipeline failures, Eli Lilly and Co. is on a bit of a hot streak. This month alone, the Indianapolis-based drugmaker has reported positive results from clinical trials of four experimental drugs.
Congressional Republicans will move to temporarily continue health care subsidies for millions of people if the Supreme Court overturns the aid, according to plans discussed Wednesday in the House and Senate.
Life insurer has boomed by handling employer retirement plans, offering long-term care policies.
